APCDD Antibodies

Santa Cruz Biotechnology provides a broad selection of APCDD monoclonal antibodies for advanced research in cellular signaling and development. APCDD monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). APCDD, or Adenomatous Polyposis Coli Down-Regulated 1, plays a crucial role in the regulation of Wnt signaling pathways, which are essential for cell proliferation, differentiation, and tissue homeostasis. Dysregulation of APCDD has been implicated in various cancers and developmental disorders, making it a significant target for therapeutic research. Understanding APCDD function is vital for elucidating the mechanisms underlying these diseases and developing potential interventions. Researchers worldwide rely on APCDD monoclonal antibodies to investigate cellular pathways and disease mechanisms. Current studies focusing on APCDD continue to reveal new insights into its role in development and disease progression. APCDD monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding and potentially develop new therapeutic strategies.